Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

Chronic Obstructive Pulmonary Disease II: Emphysema

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...

Chronic Inflammation: Introduction

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Macrolide maintenance therapy in chronic inflammatory airway diseases: A survey of French pulmonologist's practices.

Respiratory medicine and research·2026

Same author

Computational fluid dynamics and genotyping to explore airborne transmission of respiratory viruses in hospitals.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Same author

The importance of disease coding following the diagnosis of chronic kidney disease: From ICD-10 code N18.9 to the role of clinical laboratories.

Nefrologia·2025

Same author

The LEAP Study: A Multicenter Biospecimen and Imaging Resource for Lung Cancer Screening.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2025

Same author

Cardiopulmonary Hemodynamic Determinants of Long-Term Survival in Sickle Cell Disease: Insights from the ETENDARD Study.

American journal of respiratory and critical care medicine·2025

Same author

Bronchiectasis in France: data on disease characteristics in 630 patients from the European Bronchiectasis registry (EMBARC).

Respiratory medicine and research·2025

Search research articles

Related Experiment Video

Updated: May 29, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Telomere dysfunction causes sustained inflammation in chronic obstructive pulmonary disease.

Valerie Amsellem¹, Guillaume Gary-Bobo, Elisabeth Marcos

¹Institut National de la Santé et de la Recherche Médicale, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France.

American Journal of Respiratory and Critical Care Medicine

|September 3, 2011

Summary

Telomere dysfunction and premature pulmonary vascular endothelial cell (P-EC) senescence drive chronic inflammation in COPD. This study found increased senescent P-ECs and shorter telomeres in COPD patients, perpetuating lung inflammation.

More Related Videos

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome

Published on: June 2, 2022

Related Experiment Videos

Last Updated: May 29, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome

Published on: June 2, 2022

Area of Science:

Pulmonary Medicine
Cell Biology
Inflammation Research

Background:

Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation with an unclear underlying cause.
Pulmonary vascular endothelial cells (P-ECs) play a critical role in lung health and disease.

Purpose of the Study:

To investigate the role of telomere dysfunction and senescence in pulmonary vascular endothelial cells (P-ECs) as a driver of inflammation in COPD.
To determine if P-EC senescence contributes to the pathogenesis of COPD.

Main Methods:

A prospective study comparing patients with COPD to age- and sex-matched control smokers.
Analysis of lung tissue and cultured P-ECs for markers of senescence, telomere length, and inflammatory mediator release.
Utilized genetically modified mice lacking telomerase components (Tert or Terc) to model telomere dysfunction.

Main Results:

Patients with COPD exhibited a higher percentage of senescent P-ECs (stained for p16 and p21) compared to controls.
Cultured P-ECs from COPD patients showed signs of premature senescence, including shorter telomeres, reduced telomerase activity, and elevated inflammatory cytokine production (IL-6, IL-8, MCP-1).
Increased levels of MCP-1 and sICAM-1 correlated with monocyte adherence and migration, and these inflammatory markers were elevated in COPD lungs, correlating with P-EC senescence and telomere length.

Conclusions:

Telomere dysfunction and premature senescence of pulmonary vascular endothelial cells (P-ECs) are significant contributors to the chronic lung inflammation observed in COPD.
These cellular changes represent a key mechanism perpetuating COPD pathogenesis.